Showing results (101-110 of 355) with videos related to
Sort By:
Pageof 36
Abdominal Radiology (New York)|April 29, 2019
Extracapsular extension on MRI indicates a more aggressive cell cycle progression genotype of prostate cancerAndreas G Wibmer, Nicola L Robertson, Hedvig Hricak, et al.Urologic Oncology|June 18, 2014
Adherence to surveillance guidelines after radical cystectomy: a population-based analysisBehfar Ehdaie, Coral L Atoria, William T Lowrance, et al.Cardiovascular Diabetology|December 24, 2025
Improved sex-specific cardiovascular risk prediction with multi-omics data in people with type 2 diabetesRuijie Xie, Christian Herder, Sha Sha, et al.Urology|May 11, 2025
Effect of Age on Robotic-Assisted Radical Prostatectomy Outcomes: A Multi-center AnalysisAlec Zhu, Amy L Tin, Andrew J Vickers, et al.Cancer|November 11, 2011
Androgen deprivation and thromboembolic events in men with prostate cancerBehfar Ehdaie, Coral L Atoria, Amit Gupta, et al.The Journal of Urology|June 30, 2015
Age is Associated with Upgrading at Confirmatory Biopsy among Men with Prostate Cancer Treated with Active SurveillanceChristopher B Anderson, Itay A Sternberg, Gal Karen-Paz, et al.The Journal of Urology|September 11, 2013
The impact of repeat biopsies on infectious complications in men with prostate cancer on active surveillanceBehfar Ehdaie, Emily Vertosick, Massimiliano Spaliviero, et al.BJU International|May 5, 2012
Systematic classification and prediction of complications after nephrectomy in patients with metastatic renal cell carcinoma (RCC)Jonathan L Silberstein, Ari Adamy, Alexandra C Maschino, et al.European Urology|May 12, 2020
Routine Use of Magnetic Resonance Imaging for Early Detection of Prostate Cancer Is Not Justified by the Clinical Trial EvidenceAndrew Vickers, Sigrid V Carlsson, Matthew CooperbergEuropean Urology Focus|August 15, 2017
Impact of Prostatic-specific Antigen Threshold and Screening Interval in Prostate Cancer Screening Outcomes: Comparing the Swedish and Finnish European Randomised Study of Screening for Prostate Cancer CentresLasse Saarimäki, Jonas Hugosson, Teuvo L Tammela, et al.Pageof 36